Diffuse optical imaging ͑DOI͒ may be a beneficial diagnostic method for women with mammographically dense breast tissue. In order to evaluate the utility of DOI, we are developing broadband diffuse optical spectroscopy ͑DOS͒ to characterize the functional origins of optical signals in breast cancer patients. Broadband DOS combines multifrequency intensity-modulated and continuous-wave nearinfrared light to quantify tissue absorption and scattering spectra from 650 to 1000 nm. Values of intrinsic physiological properties ͑oxyand deoxy-hemoglobin, water, lipid, and scatter power͒ derived from absorption and scattering spectra provide detailed information on breast physiology. We present the results of clinical studies of 58 stage II/III malignant breast tumors using a noninvasive, handheld, broadband DOS probe. On average, eight positions were scanned over tumor and contralateral normal breast for each subject. Intrinsic physiological properties were statistically significantly different for malignant vs. normal tissues for all subjects, without patient age or tumor size/type stratification. Breast tissues containing malignant tumors displayed reduced lipid content ͑ϳ20% ͒ and increased water, deoxy-, and oxy-hemoglobin ͑Ͼ50% each͒ compared to normal breast tissues. Functional perturbations by the tumor were significantly larger than functional variations in normal tissues. A tissue optical index ͑TOI͒ derived from intrinsic physiological properties yielded an average two-fold contrast difference between malignant tumors and intrinsic tissue properties. Our results demonstrate that intrinsic optical signals can be influenced by functional perturbations characteristic of malignant transformation; cellular metabolism, extracellular matrix composition, and angiogenesis. Our findings further underscore the importance of broadband measurements and patient age stratification in breast cancer DOI. © 2006 Society of Photo-Optical Instrumentation Engineers.
Introduction

Current Methods
The most effective screening technique presently employed for breast cancer is X-ray mammography; however, performance can be severely limited by high breast density. 1 Mammography has up to a 22% false negative rate in women under 50 years of age 2 and cannot accurately distinguish between benign and malignant tumors. 3, 4 Sensitivity/specificity can range from 62.9% / 89.1% in women with extremely dense breasts, to 87.0% / 96.9% in women with almost entirely fatty breasts. 5 Digital mammography has shown similar overall di-agnostic screening accuracy when compared to conventional film mammography, although some improvement over conventional film mammography has been observed in women under the age of 50. 6 Mammography has had favorable results when coupled with physical examination for monitoring the effectiveness of neoadjuvant chemotherapy. 7 However, the presence of fibrotic tissue, 7 high mammographic density, 8 remaining microcalcifications, 7, 8 or ill-defined tumors, 9, 10 makes response difficult to correlate with pathology or prognosis. 8, 9, [11] [12] [13] Because of the variable performance of mammography in certain populations and settings, the use of optical methods as a supplement to present techniques for diagnosing and detecting breast cancer has generated considerable interest. Optical methods are advantageous because they are noninvasive, are fast, are relatively inexpensive, and pose no risk of ionizing radiation. In order to establish a better basis for optical detection and diagnosis based on differential functional contrast, factors that affect the optical properties of both normal and tumor-containing breast tissue must be carefully examined and characterized.
Noninvasive frequency-domain photon migration ͑FDPM͒ methods have successfully detected the presence of small palpable breast lesions in women with previously diagnosed breast abnormalities. [14] [15] [16] [17] [18] FDPM methods have also been used to monitor the effectiveness of chemotherapy [19] [20] [21] [22] and have been shown to correlate with measurements of mammographic density. 23 However, no clinical studies have been reported that characterize complete tumor NIR absorption and scattering spectra and physiological properties in a large population.
Diffuse Optical Spectroscopy
Diffuse optical spectroscopy ͑DOS͒ employs photon migration models and technology to probe a large sample volume, providing macroscopically averaged absorption and scattering properties at depths up to a few centimeters. The term "photon migration" refers to photons propagating diffusely throughout the tissue ͑i.e., in a random direction͒. 24 Quantitative DOS is based on time-or frequency-domain photon migration ͑FDPM͒ technology. In FDPM, near-infrared ͑NIR͒ light intensity modulated over a range of frequencies is used to characterize tissue in terms of optical parameters, i.e., the reduced scattering coefficient ͑ s Ј͒ and absorption coefficient ͑ a ͒.
The concentration of significant breast tissue light absorbers in the NIR ͑deoxyand oxy-hemoglobin, water, and fat͒ can be calculated using the measured tissue a . 25, 26 Tissue scattering properties ͑ s Ј͒ are believed to depend mostly upon intracellular structures such as nuclei 27, 28 and mitochondria, 29 although extracellular components such as collagen also play a prominent role. [30] [31] [32] Cancer cells in suspension have been shown to differ in scattering from comparable normal cells. 33 Absorption and scattering together provide an understanding of changes in tissue composition and structure that are consistent with tumor growth. Factors such as total hemoglobin concentration ͑THb͒, tissue hemoglobin oxygen saturation ͑stO 2 ͒, and the spatial heterogeneity of the scattering parameter can serve as criteria for distinguishing between malignant and benign tissue. 17 
Spectroscopy Enhances Optical Methods
DOS instruments generally make use of only a few wavelengths and a limited number of source modulation frequencies. These instruments typically sacrifice spectral and modulation bandwidth for speed or imaging capability. We have developed a broadband DOS method based on a combination of multi-frequency intensity-modulated and continuous-wave spectroscopies to quantify thick tissue optical properties. 34 Our technical strategy uses the spectral scattering dependence and absolute absorption values obtained from discretewavelength multi-frequency FDPM measurements in order to translate broadband reflectance data into diffuse absorption and scattering spectra. 35 These NIR spectra provide insight into breast tissue composition and function.
NIR absorption spectra are sensitive to several important physiological components in breast tissue such as oxyhemoglobin ͑ctO 2 Hb͒, deoxy-hemoglobin ͑ctHHb͒, water ͑ctH2O͒, and lipids. * [30] [31] [32] [36] [37] [38] [39] [40] [41] Most optical mammography studies have focused upon the hemodynamic component of breast tissue, often ignoring or assuming water and lipid concentrations. Many of these studies have demonstrated that enormous hemodynamic contrast is available to NIR optical mammography. 15, 18, 23, 42, 43 Oximetry measurements based upon discrete wavelengths can present problems in the recovery of hemodynamic parameters. 30, [44] [45] [46] This is especially true in the breast, where the hemoglobin absorption is relatively small 30 and the compounding effect of water absorption plays a larger role. 44 Although it is possible to achieve accurate tissue hemoglobin saturation measurements with two optimized wavelengths, the choice of these wavelengths depends upon the optical properties of the tumor. 47 Algorithms may be used to optimize wavelength selection, or to spectrally weight component analyses, but without any a priori information it is prudent to have as many wavelengths as possible.
Although often ignored by the optics community, tissue water has received much attention in the MRI community. The apparent diffusion coefficient ͑ADC͒ of water is a measure of the diffusion of bulk water in tissues. The ADC of water has been found to correlate with cellular density ͑or cellularity͒ in several tissues, including brain, [48] [49] [50] [51] breast, [52] [53] [54] and bone marrow. 55, 56 Detailed studies using human melanoma xenografts 57 and breast tumor animal models 58 have supported these findings. The ADC of water has also been found to relate to cellular pathology. 56, 59 Most relevant to our discussion are the ADC of water differences displayed by benign and malignant breast lesions. 52, 53 The ADC of water is lower in malignant lesions relative to normal tissues because the higher cellularities in malignant tissues often slow down the diffusion of water. Thus, the ADC of water, and perhaps the corresponding increases in water concentration, can provide a link to the cellular microscopic environment.
Lipids also play a role in optical mammography. Coregistered measurements of optical and MRI data in homogeneous tissue phantoms have shown both techniques measure lipid and water concentrations with high accuracy. 60 In some cases, a breast may be viewed in the simplest fashion as a layer of lipids surrounding a layer of glandular tissue. However, this is not always true, and breast lipids strongly change with age and, in particular, menopausal status. The effects of lipids, especially as a layer, can dramatically influence efforts for quantitative image reconstruction if ignored. 61 Benign lesions such as lipomas and perhaps cysts can be identified by the lipid content. 40
Project Goal
The goal of this study was to identify the NIR functional contrast between normal breast tissue and breast tissue with malignant tumors within a small but statistically relevant population of subjects. We define contrast in this contribution as the difference between malignant and normal tissues. The *Our notation is designed to comply with the suggestions of Zander and rich spectral content in these studies clearly demonstrates the clinical potential of quantitative NIR tissue spectroscopy. In addition, we expect that this information will be useful for identifying regions of optimal spectral contrast in the development of optical tomographic and imaging techniques.
Methods
Absorption Spectroscopy in Diffusive Media
The intense multiple scattering nature of tissues greatly increases the photon path length, which complicates measurements of tissue absorption coefficients. The photon path has been shown to vary considerably in many tissues and is thus not usually known a priori. We have employed FDPM theory in order to separate the effects of absorption and scattering in tissues. The technical aspects of this theory have been discussed in the literature. 62, 63 Specifically, we have used a P 1 approximation to the transport equation in the semi-infinite geometry using an extrapolated boundary condition. 64, 65 
Instrumentation
The specific details of broadband DOS have been described elsewhere. 35, 66 Briefly, the instrument is comprised of two key components: a 6 wavelength frequency-domain component and a broadband steady-state component ͑Fig. 1͑a͒͒.
The FDPM instrument currently employs six commercially available laser diodes ͑661, 686, 786, 808, 822, and 852 nm͒; older versions of this instrument included additional laser di-odes at 911, 956, and 973 nm. Each laser diode is amplitude modulated serially between 50 to 500 MHz in steps less than 2 MHz by combining a DC bias current and RF modulation current provided by a conventional network analyzer. A 3-mm fiber bundle, composed of six 400-micron-diameter fibers, delivers the laser light to the subject. Each laser delivers less than 20 mW of optical power to the tissue.
A hand-held probe houses an avalanche photodiode detector ͑APD͒ that records modulated diffuse light signals after propagating through the tissue ͑Fig. 1͑b͒͒. The particular APD we have used ͑Ͻ1 mm 2 active area, 600 MHz 3 dB cutoff point͒ is housed inside a sealed module. This hand-held probe has a plastic attachment on the casing to position source optical fibers at variable distances from the APD. The network analyzer acts as a fast electronic heterodyning digitizer by comparing a small fraction of the source electronic signal with the electronic signals generated by the APD. Thus, the phase and amplitude of the detected diffusive optical signals are measured as a function of source modulation frequency. The total FDPM measurement time is approximately 20 s. However, the actual sweep and acquisition time is actually only 200 ms per wavelength.
It is not possible to implement hundreds of laser diodes to cover the entire NIR spectral region. Additionally, we have found by experience that the source modulation depth of laser diodes higher than 900 nm tends to be much lower than for laser diodes between 600-850 nm. This lower modulation depth decreases the measurement signal to noise, particularly at higher modulation frequencies. To increase the spectral bandwidth, we have integrated a steady-state ͑SS͒ spectrometer system into our instrument. 35 The integrated SS system interpolates and extrapolates values of a in regions where laser diodes are not commercially available. In addition, we have found this combined technique does not require laser diodes beyond 900 nm. However, the SS spectra must be acquired alongside the FDPM information in order to produce absolute quantitative absorption spectra, for reasons that are described ahead.
Fitting Considerations
FDPM instrumentation artifacts such as cable length and source strength variability introduce additional unwanted phase shifts and amplitude decreases. These artifacts were removed by calibrating the measured photon density wave phase and amplitude with the phase and amplitude of light detected in a tissue-simulating phantom with known optical properties. 66 A standard integrating sphere was also used to remove wavelength-dependent artifacts from the SS source, spectrometer, and optical fibers.
By fitting instrument-corrected data to a P 1 approximation to the radiative transport equation, we can recover a independently from s Ј for the tissue. We typically fit data from 50 to 500 MHz while keeping the source detector separation fixed in order to recover a and s Ј; thus, only a single distance is needed for optical property measurements. A Levenberg-Marquardt minimization algorithm was adapted to fit simultaneously both the real and imaginary parts of the signal ͑i.e., phase and amplitude͒ by minimizing a 2 merit function. Several initial guesses were used to verify that the minimum 2 was not strictly a local minimum. This FDPM fit Fig. 1 Instrument diagram. The current cart-based clinical system combines a six-wavelength frequency-domain instrument ͑660-850 nm͒ with a broadband steady-state spectrometer system ͑650-1000 nm͒ depicted in panel ͑a͒. The handheld probe, which is placed upon the breast tissue region of interest, is diagrammed in panel ͑b͒. "S" is the RF source, "R" is the RF reference, and "D" is the RF detection channel.
was accomplished using the 'lsqcurvefit' routine in MAT-LAB™. The end result is a discrete spectrum of a and s Ј values at each of the laser diode wavelengths.
SS broadband spectra were converted into absolute absorption spectra using two simple steps. First, the spectral shape of the reduced scattering is assumed to follow a power law 67, 68 of the form s Ј=A −sp , where A is the scatter amplitude and sp is the scatter power, or the exponent of the scattering spectrum. The power-law fit to the FDPM discrete laser diode spectrum provides a scatter correction of the SS reflectance spectrum. Second, we fit the SS intensity at each of the laser diode wavelengths to the FDPM-measured absolute absorption values. Thus, the SS reflectance spectrum intensity is scaled using the FDPM discrete laser diode measurements. The absolute absorption spectrum is then extracted by fitting the corrected reflectance spectrum to a diffusion model 69 using the 'fzero' function of MATLAB™.
In a typical measurement, we measured the tissue twice, and then measured the phantom several times. This procedure provided precision errors that emerged from coupling variability between the probe to the phantom and from the probe to the tissue. The biggest variation in our measurements was due to the variability in coupling to the phantom.
Spectral Processing
Complete details of the processing of typical DOS data have been described. 30, 34 The absorption spectrum provides the information needed to solve a weighted, nonzero, least-squares problem ͑using 'lsqlin' in MATLAB™͒ to recover the concentrations of the principal NIR absorbers. No a priori knowledge about these chromophore concentrations has been assumed ͑other than standard non-negative constraints͒. Each matrix is overconstrained because we measure many more wavelengths than chromophores. We assumed that the only chromophores were H 2 O, lipids, O 2 Hb, and HHb. Molar extinction values for water were obtained from Kou et al. 70 Molar extinction values for lipids ͑soybean oil͒ were obtained from Eker. 71 Oxy and deoxy hemoglobin molar extinction coefficients were obtained from Zjilstra et al. 72 Other NIR chromophores such as myoglobin and cytochromes were assumed negligible in breast tissue and therefore ignored.
In Vivo Measurements
A series of broadband DOS measurements were taken on a population of 58 malignant breast tumors in 57 subjects. General patient information may be found in Table 1 . The mean subject age was 50.5 ͑13.8͒ with a range of 18 to 81. The mean body-mass index ͑BMI͒ was 27.5 ͑7.1͒, with a range of 18.8 to 47.8. Linear reflectance linescans were performed in all subjects both over the region of the tumor and in the same location on the contra-lateral side ͑Fig. 2͒. The linescan location was chosen based upon a priori knowledge of the tumor location from standard X-ray mammography; thus, the intent of this data was not to screen for suspicious lesions but to characterize malignant lesion optical properties. We assumed that the contralateral side was normal tissue unless otherwise indicated in the final pathology report. For mastectomy patients ͑N =3͒ we used the opposite side of the same breast as the normal tissue region, unless otherwise indicated in the pathology report.
Linescans were generally performed in 10-mm steps ͑a few were 5 mm͒ using a source-detector separation of 28 mm. Measurements were repeated twice to evaluate placement errors at each grid location. Characteristics of the tumors studied in this paper are presented in Table 2 . The average tumor size, which was taken to be the maximum tumor dimension, was 27± 21 mm, with a range of 5 to 113 mm ͑reported for 55 of 58 tumors͒. The average Bloom-Richardson score was 6.2± 1.5, with a range of 3 to 9 ͑reported for 37 of 58 tumors͒. All tumor classifications were evaluated by standard clinical pathology.
Linescan Geometry Characterization
Given the diffusive nature of light, tumor linescans can be convolved with regions of normal tissue. In our reflectance geometry, the fraction of tumor to normal tissue depends upon the location of the lesion along the linescan axis and the lesion depth. We considered various simple means for characterizing the optical and physiological properties of linescans, as depicted by an arbitrary DOS parameter in Fig. 3 . First, we calculated the average value of the parameter for all linescan locations ͑T AVG ͒, as indicated by the dotted line. We then determined the parameter maximum value, which is denoted by the term T MAX . This linescan location was assumed to be the best single location that represented tumor tissue. In order to represent a larger volume of tissue, we defined a value T PEAK , as shown by the angled dotted ellipse, which is defined as the average parameter at the three highest continuous points in the linescan, one of which was T MAX . Finally, we located the lowest continuous parameter value on the tumor linescan, which was usually the farthest away from T PEAK , and averaged them to obtain a tumor-side normal baseline ͑T BASE ͒. As for the contralateral normal side, we always report the average of the linescan ͑N AVG ͒.
In order to locate the lesion, we used a previously proposed contrast function known as the Tissue Optical Index ͑TOI͒. 39 Since in general, we have found that tumors possess higher concentrations of water and total hemoglobin, lower lipids and stO 2 , we decided upon the following original function: 
Thus, the location of T MAX , unless otherwise noted, is taken to refer to the point on the linescan where TOI is a maximum. All tumors in this study displayed contrast differences in this TOI parameter between the tumor linescan and the normal issue linescan. However, as we detail in Sect. 4, we have observed in this statistical study that the stO 2 is not as sensitive as the base DOS parameters such as ctHHb and ctH 2 O. Additionally, we also desire an index that is itself not a function of other indices ͑namely, ctTHb and stO 2 ͒. For these reasons, we have elected to represent the hemodynamic contribution to this index by hemoglobin parameter, ctHHb. Thus, the updated index becomes
For the purposes of this study, we have found that both the revised and original TOI functions report similar results in terms of spatial location of maximum lesion contrast with respect to a normal tissue baseline. The updated TOI, however, generally reports higher relative contrast.
Statistical Considerations
Nonparametric statistics were used for all statistical tests to remain free of normality assumptions. Comparisons between tissue regions were performed using two-tailed Wilcoxon/ Kruskal-Wallis Rank Sums tests. Significance was assumed at a confidence interval of 95% ͑␣ = 0.05͒ for a two-tailed dis- Fig. 2 Linescan geometry. The handheld probe was moved along a linear grid of steps spaced 10 mm apart. Each point of the linescans was measured twice ͑the resulting fitted spectra are shown͒. Both the tumor region ͑which had been previously identified͒ as well as the contralateral normal side was measured. In the event of mastectomy, the opposite side of the same breast was scanned. Note that the orientation, location, and number of points of the linescan varied with the clinical presentation of the lesion. tribution. We further assumed that all measurements were independent. All statistical calculations were performed using commercial software ͑JMP IN; SAS Institute, North Caro-lina͒. Error bars for population data are the standard deviation of the population ͑i.e., not the standard error of the mean͒.
Study Limitations
The purpose of this study was to determine the diffusive optical signatures of malignant lesions in breast tissue. In all cases, tumor general locations were known a priori, as denoted by standard X-ray mammography. Thus, our results should not be interpreted as the findings of a screening study. Data were not stratified into classification categories beyond malignant and normal. Another limitation is that we did not consider benign lesions in this study. Differentiation between malignant and benign tumors is a challenging diagnostic problem. We did not have enough benign lesion statistics to make meaningful comparisons and thus they were not included in this study. In the interest of simplicity we felt it was best to relegate our analysis to malignant lesions. A study comparing the signatures of malignant and benign lesions is forthcoming.
The third limitation of this study is that depth information was not always available. All tumors were identified via standard mammography, but modalities that typically report depth ͑such as MRI and ultrasound͒ were not routinely available. Thus, the actual values of tumor versus normal will be skewed with the depth. Nevertheless, this dataset reports the nature of the contrast available.
Five subjects who fit the criteria described in this report were measured but not included in this analysis. One patient measurement was discarded because of technical problems during the control measurement on normal breast tissue. Another subject was excluded because of un-physical lipid and water values ͑i.e., beyond 100%͒, which may be the result of excessive tumor edema or improper calibration. In another subject, the tumor signature was identified, but the control side displayed one point of unusually high TOI contrast ͑comparable to the tumor͒ that could not be explained. In the two remaining subjects, no TOI contrast was detected, presumably because the lesion location was not properly identified or the lesion was too deep for our source-detector separation to probe adequately.
Results
Basic Characteristics of Tumor Spectra
How do tumor spectra differ from normal tissue spectra? Figure 4͑a͒ provides typical spectra from a malignant tumor in the breast of a 51-year-old female subject with a 2.3ϫ 1.6 ϫ 1.9 cm adenocarcinoma. Panel ͑a͒ presents the measured a spectrum from 650 to 1000 nm in a region of tumorcontaining tissue. There are several prominent spectral features displayed. There is a large peak in the 930-nm region that is characteristic of lipids, which are plentiful in normal ͑and especially postmenopausal 30, 32 breast. There is also a prominent peak in the 970-nm region that is characteristic of a high water concentration. 19, 30, 40, 73 Typically this water value ͑c͒ presents the scattering information as represented by the prefactor and scatter power according to a power law description with s Ј in mm −1 , and in m. Note carefully that the parameters do not all peak/trough at the same location. Panel ͑d͒ provides a summary by displaying the TOI, both old and updated, for these linescan data. Error bars represent the differences between the two linescans.
is lower in normal postmenopausal breast tissue. 30, 32 The peak near 760 nm is a well-known spectral characteristic of deoxyhemoglobin. Normal breast tissue, particularly in postmenopausal women, contains very little hemoglobin compared to other tissues such as muscle and brain. 30, 31, 74, 75 Overall, the absorption begins to increase in the red part of the spectrum, especially in the 600-nm region where hemoglobin absorption becomes very large. The solid line in Fig. 4͑a͒ is a fit of the four-component basis spectra ͑HHb, O 2 Hb, H 2 O, lipid͒ to the measured a . Figure 4͑b͒ presents the measurement of the reduced scattering in tumor-containing tissue in the same patient. The six points represent the FDPM-measured s Ј values, and the line represents the nonlinear power law fit to these data. In general, we have found that both scatter amplitude and scatter power were strongly correlated. Figure 4͑c͒ is a comparison between the absorption spectra of tumor-containing breast tissue ͑the same spectrum as above in Fig. 4͑a͒͒ and the absorption spectra from the same location on the contralateral side ͑i.e., presumed normal, dotted line͒. Immediately we can see characteristics that differ between the tumor and normal spectra. The tumor region contains higher levels of water and reduced levels of lipid, as evidenced by increased absorption at ϳ970 nm and decreased absorption at ϳ930 nm, respectively. A significant increase in tumor hemoglobin is indicated by changes in absorption between 650 and 850 nm. By applying the results of the four-component basis spectra fit we can generate quantitative concentrations for the components.
Basic Linescan Characteristics of Tissue Properties
How do these calculated DOS-measured parameters vary spatially across the linescan? Figure 5 provides the calculated concentrations plotted as functions of linescan position for a 10ϫ 15ϫ 10 mm tumor in the breast of a 39-year-old sub-ject. Points on this grid are separated by 5 mm, as indicated in the figure. Error bars represent differences between the two linescans ͑ϳ10% ͒. The lesion was an infiltrating ductal carcinoma, with less than 10 mm diameter along the largest axis. We observe in Fig. 5͑a͒ an increase in tissue hemoglobin near the −10-mm location, both in oxy and deoxy forms. These values are to be compared with the tissue baseline, which for our purposes is located at positions +15 & +20 ͑20-30 mm away͒. There also exists a strong peak in the water concentration, but at the center of the linescan. A trough exists in the lipid fraction at the −10-mm location. Figure 5͑b͒ continues by demonstrating a peak in ctTHb at the −10-mm location, but a trough in the stO 2 at the +5-mm location. The scatter power expresses a peak at the center of the linescan ͑as does the water͒, but note that the lowest portion of the linescan exists in the −10-mm position in Fig. 5͑c͒ . That all parameters do not peak or trough at the same spatial location is noted. We can assemble multiple functional parameters from Fig.  5͑a͒ into a single index to enhance the differences between normal and tumor. Figure 5͑d͒ provides two such indices. The bottom curve ͑circles͒ is a plot of the original TOI parameter ͓Eq. ͑1͔͒, which demonstrates a maximum at the −10-mm location and a peak-to-baseline contrast ratio ͑T MAX / T BASE ͒ of about 2. The top curve ͑squares͒ represents the newer TOI index ͓Eq. ͑2͔͒, which demonstrates a maximum at the same location.
Population Statistics: Average Values
Are these DOS-measured differences preserved over a larger population? To test this hypothesis, we performed comparisons of all measured and calculated parameters for the entire population of 58 malignant tumors. Table 3 provides the results of comparisons between the tumor and contralateral normal linescan averages ͑T AVG and N AVG , respectively͒. For each linescan we calculated both the mean and the median Significance was achieved at the 95% confidence interval using a two-tailed distribution. In particular, the variance in A was quite large, mostly due to some very extreme values. So as to not skew the average, we instead report the natural logarithm of the values, noting that statistical significance was still observed with the nonparametric test. As for calculated indices, the ctTHb displayed statistical significance while the stO 2 did not. Thus, the inclusion of stO 2 in the TOI may not be justified in every case. As described by Eq. ͑2͒, we replaced the ratio of ctTHb/ stO 2 with the most sensitive hemodynamic parameter, ctHHb. Table 3 demonstrates that differences between N AVG and T AVG differ in statistically significant fashion according to the two-tailed Wilcoxon Ranked-sum test ͑Z = 0.0013͒. Note that the data presented are the natural logarithm of the TOI since the range of TOI values is quite high. The contrast ratio between N AVG and T AVG in TOI was the highest amongst all the parameters ͑ϳ factor of 3͒.
Population Statistics: Tissue Variations vs. Tumor Perturbations
The average linescans in effect average out the differences between tumor and normal because the tumor linescan includes several points far from the lesion site. But how do the tumor features compare relative to the intrinsic physiological variations of normal tissue? Table 4 provides the average and median contrast difference in DOS base parameters for the tumor with respect to the background, which is defined as ⌬T = T MAX − T BASE for all 58 subjects. In addition, we compare the ⌬T with the standard deviation of the contralateral normal breast ͑N SD ͒ for each DOS parameter. A value of unity implies that the physiological perturbation by the tumor is on average the same as the intrinsic physiological variation in normal tissues. The results are in general the same as for the tumor averages, but we can now understand these variations as a physiological signal-to-noise. The strongest average relative contrast belongs to ctH 2 O ͑ϳ8.2͒ and ctHHb ͑ϳ7.3͒, followed by lipids and ctO 2 Hb ͑ϳ3.5 each͒ and then finally by the SP ͑Ͻ2͒. We note that the lipid difference is negative because lipids tend to decrease in the presence of a tumor. We confirmed that ⌬T was significantly different than the NSD for all DOS base parameters ͑Wilcoxon, p Ͻ 0.0001͒.
Age-Related Absorption Spectra Comparison
We plot the average T MAX spectrum against the corresponding average T BASE spectrum in Fig. 6͑a͒ . Error bars represent the standard error in this case and are plotted only every 50 nm for clarity. The general features of the previous analysis are demonstrated here, such as higher absorption in the hemodynamic range and especially higher water absorption. We note that there is considerable variation amongst the T PEAK spectra, 
Fig. 6
Composite of all tumor absorption spectra. Panel ͑a͒ provides the averages for all T MAX and T BASE absorption spectra for the 58 tumors patients in the study. We have stratified the T MAX spectra them according to an age-dependent breakdown as discussed in the text. Note the clear changes between pre-and post-menopause, particularly in the 900-nm and above spectral region. Panel ͑b͒ groups the spectra into three age categories: A ͑under 40͒, B ͑40-50͒, and C ͑over 50͒. Note each age category generally represents pre-menopause, peri-menopause, and post-menopause for categories, A, B, and C, respectively.
and less variation amongst the T BASE spectra. It is noteworthy that although statistically we observe differences between the spectra, the measured spectra also exhibit some degree of overlap. For example, there are normal subjects who display ctHHb values that are higher than other subjects with tumors. We can gain some insight into this effect by plotting each of the T MAX spectra for three age groups in Fig. 6͑b͒ : Ͻ40͑N =16͒, 40 to 50 ͑N =10͒, and Ͼ50 ͑N =32͒, We note that the average spectrum appears age-dependent. As subjects age, with a menopausal transition at about 51 years, we can see the clear differences in tumor spectra between younger and older women.
The differences between younger and older women can be quantified by averaging the fitted components according to age category. Table 5 provides within each age category the average of the difference between T MAX and T BASE , where errors here are again the standard error of the mean. While it is clear that there are differences in baseline functional properties between ages, we observe that the differences between T MAX and T BASE are age-dependent. In addition, we note that the differences between T MAX and T BASE ͑i.e., tumor contrast͒ are greatest in the spectral features above 900 nm ͑ctH 2 O and Lipids͒. Nonparametric Kruskal-Wallis tests with the Bonferroni correction ͑where p = 0.05/ 3 = 0.017 implies signifi-cance͒ confirm that the age categories are not representative of the same population, with significance probabilities of 0.001 for ctHHb, 0.002 for ctO 2 Hb, Ͻ0.001 for ctH 2 O, and 0.002 for lipids.
Scattering Spectra
We have also plotted for all 58 subjects the fitted scatter amplitude versus the fitted scatter power for three classes of measurements: N AVG , T BASE , and T MAX in Fig. 7 . In each case, there is a high degree of coupling between the scatter amplitude and scatter power. The lines are semi-log fits to these data for each measurement class. The slopes of the lines are 3.57± 0.15 ͑r = 0.95, p Ͻ 0.0001͒, 3.23± 0.10 ͑r = 0.97, p Ͻ 0.0001͒, and 2.90± 0.08 ͑r = 0.98, p Ͻ 0.0001͒ for N AVG , T BASE , and T MAX , respectively. The power-law fit comprises six wavelengths ranging from 660 to 850 nm.
Using nonparametric statistics as before, we verified that the A to SP ratio changed significantly between N AVG and T MAX ͑p = 0.01͒. Likewise, the A and SP ratio changed significantly between T BASE and T MAX ͑p = 0.02͒. In contrast, the A and SP ratio was not found to be significantly different between T BASE and N AVG ͑p = 0.97͒. For this reason, a threeway comparison ͑Kruskal-Wallis͒ between the A to SP ratio at each of the three measurement locations was not found to be significant ͑p = 0.02͒ after adjusting the significance level using the Bonferroni correction for multiple comparisons.
Effect of Tumor Size
Although this was not an imaging study, we report the effect of tumor size on the linescan measurements. The maximum tumor size was chosen because it was the most consistently reported measure of tumor size. Our analysis also does not take into account the actual tumor orientation. We did not observe any correlation between the maximum tumor size and the tumor peak values ͑Fig. 8͒ for each of the base absorptionderived DOS parameters. The maximum tumor size was determined from the pathological and radiological findings. There will be of course some discrepancy between pathological and radiological distances but not enough to change the results of these findings. Note that this lack of correlation does not imply this will be true for all measurements, but in our nondepth sectioned study we did not see this correlation.
There is, however, a weak correlation between the spatial extent of DOS linescans and the tumor size. The normalized area of the linescan was determined by ͑a͒ calculating the difference between TOI T PEAK and T BASE over the linescan, and ͑b͒ scaling the result between 0 and 1. In this way, nontumor linescan locations contribute zero whereas the maximum contributes a value of 1. By normalizing the data, we have removed all age-dependent effects and focused solely on the spatial characteristics of the linescans. Table 6 outlines a breakdown of 46 lesions in terms of size. We included only 46 of the 58 lesions because ͑a͒ 3 lesion sizes were not reported in the radiological or pathological reports, and ͑b͒ 9 linescans did not cover the entire lesion, and thus the area calculation would not faithfully represent the tumor volume. In general, the size categories were chosen to reflect similar numbers of counts, using as small of a distance range as possible; note that the last few categories, for which there are less counts, have wider size intervals. The size reported in this case is the maximum lesion dimension. Figure 9 provides plots of ctH 2 O, ctHHb, and ctTHb, and TOI versus the lesion size category. The error bars represent the standard deviation of all lesions that lie within each lesion size category. Although the variation is substantial, a general linear trend can be observed for all DOS-measured parameters. Of the fits, only ctH 2 O ͑0.21± 0.14, p = 0.0009͒ and ctHHb ͑0.17± 0.14, p = 0.0007͒ display a slope that is clearly greater than zero despite the errors.
Effect of Tumor Pathology
Is there a link between the macroscopically measured optical properties and the histological character of the tumor? Figure  10 plots the T MAX -value of ctH 2 O versus the Bloom-Richardson score. 76 The Bloom-Richardson score, as updated by Scarff ͑SBR͒, is a histological grading scale ranging from 3 to 9, that accounts for tubule formation, nuclear pleomorphism, and mitosis counts. 77 The SBR score was determined by pathologists, but only reported for 37 of the 58 tumors. Each SBR level for the lower categories is generally underrepresented with only N =2 for a score of 3 and N =1 for a score of 4. Error bars represent the average ctH 2 O value for each SBR score. Although the variation is high, a general pattern exists. The SBR score increases with increasing ctH 2 O with a high degree of linearity ͑R = + 0.98͒. The solid line represents an error-weighted fit to the data points; however, we excluded the SBR= 4 points because N =1 did not allow for error bars. The slope of the line was 4.36± 0.58 ͑p = 0.0004͒ and the intercept was 5.8± 3.8. We also checked the N AVG -value of ctH 2 O on the contralateral normal breast against the SBR score of the tumor. However, as expected, we failed to see any correlation ͑R 2 = 0.07͒, with an effective slope near zero ͑−0.45± 0.86, p = 0.62͒. ctH 2 O displayed the most significant correlation with SBR. The same general effect was observed for ctO 2 Hb ͑R = 0.96, p = 0.0006͒. ctHHb ͑R = 0.96, p = 0.001͒ and lipids ͑R = −0.85, p = 0.03͒ also were correlated with SBR but to a lesser degree, generally due to higher variations. Note that the lipid signal decreased with increasing SBR, but this effect is likely due to the fact that the lesion size tended to increase with increasing SBR. The correlation between SP and SBR was lower ͑R = −0.61͒ and not significant ͑p = 0.2͒. Note that the SBR= 4 point was also excluded from these errorweighted fits since there was only a single subject with SBR= 4.
Discussion
General Remarks
Broadband DOS measurements display enormous spectral sensitivity at the expense of spatial resolution. Since the tumor locations were known a priori, the low degree of spatial sampling by our technique was not a serious limitation. Measured tumor spectra likely contained contributions from both normal and diseased tissues, the balance of which varied with lesion size and depth, as well as the optical properties of the tissues within the field of view. Image reconstructions would be able to isolate the optical properties of tumor and normal tissues better than the simple scheme we have presented here. In some cases, true contrast can be higher than we have presented, although many of our stage III tumors were large enough to occupy a sizable field of view within the probe. Because the biological processes that determine the origins of optical contrast are conserved across spatial scales, intrinsic optical signals measured from these subjects are expected to be similar for earlier stage invasive cancers.
Significance of Absorption Contrast
Changes in ctHHb were the most significant of all the base parameters. We found that ctHHb generally produced the largest relative changes in the average ͑48%͒ and peak ͑68%͒ linescan values. Although ctHHb is the most sensitive parameter, additional tissue constituents such as water and lipid also produced significant differences that could aid in the detection and characterization of breast lesions. For the peak tumor val- Fig. 9 Plots of normalized tumor area versus size category. Normalized tumor area was determined by integrating DOS parameters over the tumor locations in a normalized linescan. Although there is high variation, there is a weak general trend in size. Error bars represent the standard deviation for each parameter for all subjects within a given size category. ues, we observed changes in absolute percent for lipids and water to be Ͼ13% for each parameter. Surprisingly, the stO 2 was the least sensitive figure of merit presented here. In particular, the average value of the stO 2 linescan was not significantly different than the normal linescan. The stO 2 has been commonly used as a figure of merit for breast cancer detection. According to our results, the hemoglobin concentrations themselves were far better indices for cancer detection. Even the minimum stO 2 -value of the tumor linescans averaged for all subjects was about 61%. There were patients where the stO 2 dropped significantly, as one might expect, but this was not always the case. Typically we have seen large stO 2 decreases in large necrotic tumors; a good example of this may be found in a detailed recent publication. 20 The hemoglobin concentration in the breast is relatively low, especially in the post-menopausal breast, so that small errors in concentration manifest as large errors in stO 2 . This error will only be amplified by ignoring the contribution of water and lipids. 30 We also observe that there is important contrast between normal and malignant available in the 900+ nm range ͑water and lipids͒. The extra information here may be important, although few optical mammography studies have taken advantage of the information content offered by this spectral region. Water and lipid contrast may aid in lesion detection, as evidenced by the usefulness of the TOI. As breast tumors grow, they begin to push away adipose tissue. In addition, the water may be an index of cellularity, and may thus report on the aggressiveness of the tumor. [52] [53] [54] Significant changes in water and lipids resulting from neoadjuvant chemotherapy have also been observed in DOS 19 as well as MRI. 78 Finally, water and lipid content play a role in mammographic density, which is correlated to breast cancer risk. 79, 80 
Significance of Scattering Contrast
We observed significant changes not only in absorptionderived parameters, but also in reduced scattering-derived pa-rameters. Both SP and A exhibited high variance. Nevertheless, we observed that both the tumor peak and average exhibit a higher SP and A than the surrounding regions of "normal" tissue on the tumor side as well as the contralateral breast side.
The dependence of the A as a function of SP was different for each measurement class; N AVG , T BASE , and T MAX . We found that within the errors ͓log͑A͒ versus SP͔; T MAX revealed the lowest slope. Since A is related to the density of scattering centers, and SP is related to the size of the scattering centers relative to the optical wavelength, we see that as tissues become cancerous, the balance between scatter density and size changes. That scatter density and/ or scatter size could change during malignant transformation is not surprising. For example, it is known that the nuclear/cytoplasmic ratio is greater in cancer cells relative to normal cells. Tissue cellularity, or cell density, is also known to increase in cancerous tissues relative to their normal counterparts. Our result suggests that there is a coupling between these size and density parameters as measured in heterogeneous breast tissues. The effect could be due to limitations in the diffusion model that arise by application to heterogeneous tissues. A more detailed analysis of tissue scattering parameters, and how these parameters change during malignant transformation, merits further investigation.
Past efforts have shown that as SP increases, the average scatterer size decreases. 33, 68 In particular, the work of Mourant et al. has demonstrated that tumorgenic cell suspensions have a lower SP and a higher A than normal cell suspensions. 33 Our results would seem at first to contradict these findings. However, we note that breast carcinomas such as those studied here have a glandular origin. These glandular tissues have a higher collagen content and a higher scatter power than tissues with less collagen content, such as adipose. 30 Thus, the scattering changes observed here may be more reflective of extracellular matrix fibrosis or diminished adipose than intracellular structure.
Comments on Spatial Heterogeneity
We have noted that all of the DOS-derived functional information did not peak or trough at the exact same position along the linescan. It is most likely that these effects are due to the low-spatial sampling frequency we have adopted here. The tumor depth below the surface will change with position so that each linescan point samples different combinations of tumor and normal tissue. In addition, since tumors are heterogeneous structures, each of the tumor regions themselves will also vary with spatial location. Thus, it is not surprising that we have observed variability in the minima and maxima of the DOS parameters. By introducing functional indices that take advantage of all of the optical contrast available, one can convolve this information into a single parameter ͑e.g., tissue optical index, TOI͒ that can be reflective of various functional changes in cellular metabolism, extracellular matrix composition, and angiogenesis that are consistent with malignant tumor physiology.
Comments on Tumor Size
We did not see any correlations between the tumor peak values and tumor size. However, there was a weak correlation between the spatial extent of the DOS parameters and tumor size. The ctH 2 O spatial extent signal correlated best with tumor size. These observations must be balanced with the fact that we did not take into account the lesion orientation. We note that a two-layer model of the breast will be necessary to strengthen this observation, since the presence of lipids in an adipose layer above the tumor will affect the spatial extent of the DOS linescan. In our limited-spatial sampling reflectance geometry, we are likely only probing the top regions of deeper or larger lesions. Efforts to construct a handpiece with depthsectioning capabilities are currently underway.
Almost 20% of the lesions studied ͑11/ 58͒ were below 15 mm in their largest axis. About 12% ͑7/58͒ were below 10 mm, with a low of 5 mm. These relatively small lesions were still measurable within this idealized nonscreening sample, despite both low-spatial sampling and inherent resolution limitations of diffuse optics. Since we do not have depth information for these lesions, we can only speculate as to the reason for the detectable contrast within this sample. We believe this is a direct result of the fact that the tumor perturbs a region of tissue that is larger than the tumor itself. Inflammation, fibrosis, and increased blood flow all occur on a spatial scale larger than the cancer cells, thus amplifying our sensitivity. Measuring and classifying lesions this small in a screening study would, of course, be much more difficult. Figure 10 provides preliminary evidence of a link between the microscopic environment of cancer cells and the macroscopically measured tissue optical properties. Higher SBR scores are associated with ͑1͒ lower microtubule formation, ͑2͒ increasingly varied nuclear pleomorphism, and ͑3͒ increased mitosis. 81 SBR scores are associated with prognosis; patients with smaller scores have significantly better survival than patients with higher scores. 81 SBR may also be a predictor of tumor response to neoadjuvant chemotherapy. 82 DOS-measured water content correlates with SBR ͑and tumor size͒ most likely because tissue water is related to tissue cellularity. Highly cellular tissues, such as cancer, have impeded diffusion, as evidenced by diffusion-weighted MRI. 57 Impeded diffusion implies an increase in ctH 2 O, which we have observed consistently in our studies. Thus, the degree of cellular density is linked to the SBR score through ctH 2 O. We recognize that this result is somewhat speculative given the high degree of variation in the data. We plan to confirm this result using preclinical animal models, where the SBR scores, cellularity, and ctH 2 O can be systematically controlled.
Comments on Tissue Water
Conclusions
We have presented quantitative, in vivo measurements of intrinsic optical contrast between malignant and normal breast tissues in 58 subjects. The functional origins of this contrast depend strongly upon the age of the subject and include both hemodynamic ͑ctHHb and ctO 2 Hb͒ and parenchymal ͑ctH 2 O and lipid͒ components. Although tissue scatter power and scatter amplitude are highly coupled, we found that the relationship between them changes as tissues progress from normal to cancerous. We also found a link between the microscopic histological grading scale ͑Scarff-Bloom-Richardson͒ and ctH 2 O. These high spectral content broadband diffuse optical spectroscopy ͑DOS͒ measurements provide a multidimensional view of tissue function and composition. Ultimately, we expect these data will play an important role in enhancing the performance and design of clinical optical mammography techniques.
